Research assessing both sarcopenia and Duchenne muscular dystrophy have shown the upregulation of cytokine groups in the NF-κB cytokine pathway, suggesting that where there is muscle dystrophy, we will find an upregulation of NF-κB. This evidence concerns the gene NFKB1 and sarcopenia.